{
  "pmcid": "8558348",
  "sha256": "5a938f09d529c799172703faa9e4d0cf687c6282c88c5e83deb57510dc2b5909",
  "timestamp_utc": "2025-11-10T00:09:51.978701+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.232422304832717,
    "reading_ease": 40.86601635687734,
    "word_count": 269
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Common-Iliac-Artery Skirt Technology in Iliac Artery Aneurysms"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "A retrospective analysis was conducted on 524 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with iliac artery aneurysms treated with either CST or IIAE were included."
      },
      "Intervention": {
        "score": 2,
        "evidence": "compared to internal iliac artery embolization (IIAE) in managing iliac artery aneurysms."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the effectiveness of a novel common-iliac-artery skirt technology (CST)"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the technical success rate, defined as complete exclusion of aneurysms without endoleak."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Seventy-two patients were included, with 39 in the CST group and 26 in the IIAE group."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "CST showed a significantly shorter surgery time (97.42 ± 3.891 minutes vs. 141.0 ± 8.010 minutes, p < 0.001) and hospital stay (15.35 ± 0.873 days vs. 19.32 ± 1.067 days, p = 0.009)."
      },
      "Harms": {
        "score": 1,
        "evidence": "The CST group had lower in-hospital MAEs (0% vs. 11.5%, p = 0.059) and 1-year follow-up MAEs (6.7% vs. 28.6%, p = 0.052)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 1,
        "evidence": "Supported by the National Natural Science Foundation of China and the Natural Science Foundation of Hunan Province."
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}